Evaluation of efficacy and safety profile of posaconazole for prophylaxis after allogeneic haematopoietic stem cell transplant

被引：0
|
作者：
Silva, F. [1 ]
Vazquez, L. [1 ]
Morales, E. [1 ]
Caballero, D. [1 ]
Perez-Simon, J. A. [1 ]
Sanchez-Guijo, F. [1 ]
del Canizo, C. [1 ]
Miguel, J. San [1 ]
机构：
[1] Hosp Univ Salamanca, Salamanca, Spain
来源：
BONE MARROW TRANSPLANTATION | 2009年 / 43卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S370 / S370
页数：1
相关论文
共 50 条
  • [31] Breakthrough Rhizopus infection on posaconazole prophylaxis following allogeneic stem cell transplantation
    F Schlemmer
    M Lagrange-Xélot
    C Lacroix
    R de La Tour
    G Socié
    J-M Molina
    Bone Marrow Transplantation, 2008, 42 : 551 - 552
  • [32] Endoscopic evaluation for cytomegalovirus enterocolitis after allogeneic haematopoietic stem cell transplantation
    Kakugawa, Y.
    Kami, M.
    Kozu, T.
    Kobayashi, N.
    Shoda, H.
    Matsuda, T.
    Saito, Y.
    Oda, I.
    Gotoda, T.
    Mori, S.
    Tanosaki, R.
    Murashige, N.
    Hamaki, T.
    Mineishi, S.
    Takaue, Y.
    Shimoda, T.
    Saito, D.
    GUT, 2006, 55 (06) : 895 - 896
  • [33] Haematopoietic reconstitution after autologous and allogeneic haematopoietic stem cell transplantation
    Pugachev, A.
    Mikhaylova, N.
    Golovacheva, A.
    Babenko, E.
    Estrina, M.
    Zubarovskaya, L.
    Afanasyev, B.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S306 - S306
  • [34] Breakthrough Rhizopus infection on posaconazole prophylaxis following allogeneic stem cell transplantation
    Schlemmer, F.
    Lagrange-Xelot, M.
    Lacroix, C.
    de La Tour, R.
    Socie, G.
    Molina, J-M
    BONE MARROW TRANSPLANTATION, 2008, 42 (08) : 551 - 552
  • [35] Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplant
    Solano, Carlos
    Slavin, Monica
    Shaul, Alissa J.
    Marks, David I.
    Cordonnier, Catherine
    Cornely, Oliver A.
    Pagliuca, Antonio
    Cragin, Lael
    Jarque, Isidro
    Garcia-Vidal, Carolina
    Sorensen, Sonja
    Vanness, David J.
    Charbonneau, Claudie
    Andoni Barrueta, Jon
    Peral, Carmen
    De Salas-Cansado, Marina
    Bow, Eric J.
    MYCOSES, 2017, 60 (02) : 79 - 88
  • [36] Secondary antifungal prophylaxis in paediatric allogeneic haematopoietic stem cell recipients
    Allinson, Katherine
    Kolve, Hedwig
    Gumbinger, Hans G.
    Vormoor, H. Josef
    Ehlert, Karoline
    Groll, Andreas H.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (03) : 734 - 742
  • [37] Safety of tacrolimus administration with aminoglycosides or glycopeptides after allogeneic haematopoietic stem cell transplantation
    Kato, J.
    Mori, T.
    Kohashi, S.
    Yamane, A.
    Okamoto, S.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S135 - S136
  • [38] Fatal Rhizopus Pneumonia in Allogeneic Stem Cell Transplant Patients Despite Posaconazole Prophylaxis: Two Cases and Review of the Literature
    Lekakis, Lazaros J.
    Lawson, Amber
    Prante, Jeanette
    Ribes, Julie
    Davis, Gregory J.
    Monohan, Gregory
    Baraboutis, Ioannis G.
    Skoutelis, Athanasios T.
    Howard, Dianna S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (08) : 991 - 995
  • [39] ANALYSIS OF THE EFFICACY OF LUSPATERCEPT IN THE TREATMENT OF ANEMIA AFTER ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION
    Dong, Lei
    Ma, Wei
    Chan-Chan, Liu
    Fang-Fang, Zhang
    Yue-Feng, Tian
    Ji-Cong, Liu
    Xiao-Zhen, Zhao
    Yang, He
    Xing-Yu, Cao
    BONE MARROW TRANSPLANTATION, 2024, 59 : 380 - 381
  • [40] Posaconazole concentrations after allogeneic hematopoietic stem cell transplantation
    Heinz, W. J.
    Einsele, H.
    Helle-Beyersdorf, A.
    Zirkel, J.
    Grau, A.
    Schirmer, D.
    Lenker, U.
    Klinker, H.
    TRANSPLANT INFECTIOUS DISEASE, 2013, 15 (05) : 449 - 456
12345